Sara Middler
Medical · Altoona, PANPI 1861979940
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $621 and has fallen 97.4% since, to $16 in 2024.
Across 60 payments — averaging $14.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$158
- GSK$156
- Johnson & Johnson$116
- Lilly USA, LLC$89
- Novo Nordisk$76
- Boehringer Ingelheim$55
- plus $214 from 8 others
What the payments were for
- Food & beverage$864100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $158 |
| GSK | 15 | $156 |
| Johnson & Johnson | 7 | $116 |
| Lilly USA, LLC | 6 | $89 |
| Novo Nordisk | 5 | $76 |
| Boehringer Ingelheim | 4 | $55 |
| Amgen | 3 | $51 |
| Merck | 3 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
| Novartis | 1 | $13 |
How this compares
$864 in reported general payments places this provider in the 65th percentile of 2,594 medical providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 17 | $360 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $282 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $186 |
| Doxycycline Hyclate | 41 | $168 |
| Azithromycin | 34 | $161 |
| Cephalexin | 48 | $154 |
| Fluticasone Propionate | 14 | $143 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $138 |
| Amoxicillin | 19 | $118 |
| Methylprednisolone | 19 | $89 |
| Mupirocin | 12 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $75 |
| Prednisone | 27 | $44 |
Paid to pharmacies, not to this prescriber.
Other medical in Altoona
- Jacqueline KernaghanSpringfield$426K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.